A. Sinclair Dunlop, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 60,000 shares at $65.63 ($3.9M) on 2022-08-11, disclosed to the SEC on 2022-08-12.
Open-market sale of $3.9M APLS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.63 | 30,000 | $2.0M | 50.0% |
| 2 | $65.63 | 30,000 | $2.0M | 50.0% |
| Total | $65.63 avg | 60,000 | $3.9M | 100% |
| Filing → |
| APLS | SELL | 2025-09-19 | $1.4M | — | Filing → |
| APLS | SELL | 2024-09-17 | $2.7M | — | Filing → |
| APLS | SELL | 2024-06-21 | $2.9M | — | Filing → |